Curiosin® (Curiosin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceZinc hyaluronateZinc hyaluronate
Similar drugsTo uncover
  • Curiosin®
    gel externally 
    GEDEON RICHTER-RUS, CJSC     Russia
  • Curiosin®
    solution externally 
    GEDEON RICHTER-RUS, CJSC     Russia
    • Dosage form: & nbspSolution for external use.
    Composition:

    Active substance: zinc hyaluronate, obtained by the formula: sodium hyaluronate 20.0 mg, zinc chloride 10.5 mg in one bottle;

    Excipients: potassium sorbate 10.0 mg, sorbitol 464.0 mg, water for injection up to 10.0 ml.

    Description:Colorless or slightly colored transparent viscous liquid.
    Pharmacotherapeutic group:Stimulator of tissue repair.
    ATX: & nbsp

    D.10.A.X.30   Other drugs for topical treatment of acne in various combinations

    Pharmacodynamics:

    When the hyaluronic acid interacts with water molecules, a dispersion matrix arises, replenishing the missing cellular tissue. It forms a natural supporting framework for cells involved in wound healing, increases the activity of granulocytes and macrophages, enhances fibroblast proliferation and angiogenesis. Compared with sodium hyaluronate, zinc hyaluronate has a bacteriostatic effect against many bacteria.

    Pharmacokinetics:

    When topical application is practically not absorbed, a small amount of the drug is detected in the plasma.

    Indications:

    As part of complex therapy for local treatment of poorly healing, infected wounds, shin ulcers, pressure sores, fistulas, and also to accelerate the normal healing of wounds.

    Contraindications:

    Hypersensitivity to any of the components of the drug, pregnancy, lactation.

    Pregnancy and lactation:

    There is no data on the use of the drug during pregnancy or during lactation.

    Dosing and Administration:

    Outwardly.

    Apply the solution once a day, on the damaged skin at a maximum dose of 1 drop / cm2. After preliminary washing of the wound surface with physiological saline or, if necessary, 3% solution of hydrogen peroxide, apply a few drops of Curiosin® solution to the gauze pad in an amount necessary to evenly wet the entire wound surface at a maximum dose of 1 drop / cm2. Cover the wound with a sterile gauze napkin or bandage that does not stick to the wound surface. On strongly wetting wounds the solution can be applied 2 times a day. The duration of therapy is individual and depends on the form and severity of the disease.

    Side effects:

    At the beginning of treatment, there may be a slight burning sensation, which gradually disappears.

    Very rarely in the adjoining areas of the skin, allergic reactions (irritation and contact dermatitis) are possible.

    Overdose:

    Not described.

    Interaction:

    There are no data on the interaction with other drugs.

    Special instructions:

    Does not cause photosensitivity, does not stain skin and linen.

    Form release / dosage:

    Solution for external use 0,205%.

    Packaging:

    For 10 ml of solution in a white polyethylene bottle with a dropper of colorless polyethylene, and with a white polyethylene cap.

    One bottle in a cardboard box with the attached instruction for use.

    Storage conditions:

    At a temperature of 15 to 30 ° C. Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:П N011511 / 02
    Date of registration:17.04.2009
    The owner of the registration certificate:GEDEON RICHTER-RUS, CJSC GEDEON RICHTER-RUS, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp06.10.2015
    Illustrated instructions
      Instructions
      Up